Site involvement as a predictor of airway intervention in angioedema

Laryngoscope

Volumn 121, Issue 2, 2011, Pages 262-266

  McCormick, Michael ^a   Folbe, Adam J ^a   Lin, Ho Sheng ^b,c   Hooten, Joanna ^a   Yoo, George H ^b   Krouse, John H ^d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioedema, airway emergencies; Level of Evidence: 2b

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; STEROID;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; DEMOGRAPHY; ENDOTRACHEAL INTUBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTUBATION; LARYNGOSCOPY; LARYNX; LIP; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT PALATE; TONGUE; TRACHEOSTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMA; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; LARYNGEAL DISEASES; LARYNGOSCOPY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TONGUE DISEASES; TRACHEOTOMY;

EID: 79251552284     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21277     Document Type: Article

References (10)

1. Agah R, Bandi V, Guntupalli KK., Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 1997; 23: 793-796.
2. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr., Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008; 100: 327-332.
3. Grant NN, Deeb ZE, Chia SH., Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema. Otolaryngol Head Neck Surg 2007; 137: 931-935.
4. Megerian CA, Arnold JE, Berger M., Angioedema: 5 years experience, with a review of the disorders presentation and treatment. Laryngoscope 1992; 102: 256-260.
5. Shah UK, Jacobs IN., Pediatric angioedema: ten years experience. Arch Otolaryngol Head Neck Surg 1999; 125: 791-795.
6. Sondhi D, Lippmann M, Murali G., Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest 2004; 126: 400-404.
7. Thompson T, Frable MA., Drug-induced, life-threatening angioedema revisited. Laryngoscope 1993; 103 (1 pt 1): 10-12.
8. Zirkle M, Bhattacharyya N., Predictors of airway intervention in angioedema of the head and neck. Otolaryngol Head Neck Surg 2000; 123: 240-245.
9. Mahoney EJ, Devaiah AK., Angioedema and angiotensin-converting enzyme inhibitors: are demographics a risk? Otolaryngol Head Neck Surg 2008; 139: 105-108.
10. Saxena S, Gierl B, Eibling DE., Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema. Laryngoscope 2010; 120: 62-64.